For the purposes of this study we used the Psoriatic Arthritis Magnetic Resonance Imaging Scoring system (PsAMRIS) currently being developed and validated by an ongoing Outcome Measures in Rheumatology Clinical Trials (OMERACT -based prOMERACT -based
Whether a ventilatory approach specifically designed to optimize alveolar recruitment while at the same time limiting end-inspiratory alveolar pressure could be beneficial regarding outcome remains an ongoing issue.
Removing this variability allows constant improvement through ongoing outcomes analysis and optimisation of the 'A constant' or its equivalent in IOL power calculation formulae.
Data were collected concurrent with hospitalization as part of an ongoing NICU outcomes monitoring project.
However, CANTOS, an ongoing large outcomes study, is evaluating three doses of canakinumab (50, 150 and 300 mg versus placebo) given subcutaneously on a quarterly basis for up to 5 years in order to assess the effects on cardiovascular risk reduction in post-MI patients and will provide long term safety data on canakinumab [ 20].
The latter was also a major limitation in several large clinical trials, for example, the Heart Outcomes Prevention Evaluation (HOPE) (137, 158) and the HOPE-The Ongoing Outcomes (17).
46 The HOPE/TOO (The ongoing Outcomes) study found decreased development of diabetes in the follow-up phase, suggesting an added benefit of long-term ramipril.
To investigate the value of sperm parameters to predict an ongoing pregnancy outcome in couples treated with intrauterine insemination (IUI), during a methodologically stable period of time.
Because of the possibility that publication of these trials was delayed owing to ongoing outcome assessments, we performed a planned subgroup analysis involving trials in which the recruitment status was listed as "completed".
This review provides an overview on the potential for SGLT-2 inhibitors to reduce CV risk beyond glucose-lowering effects and presents an overview of the similarities and differences of the currently six ongoing outcome trials from this class, currently involving more than 41,000 patients.
Nevertheless, while ongoing outcome studies with aliskiren in patients with heart failure and diabetic kidney disease are on their way to completion, this study does not provide evidence for the use of aliskiren as an add-on post-myocardial infarction.
